BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35008528)

  • 1. Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in β-Amyloid-Induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs.
    Sierri G; Dal Magro R; Vergani B; Leone BE; Formicola B; Taiarol L; Fagioli S; Kravicz M; Tremolizzo L; Calabresi L; Re F
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cdc42/Rho kinase in apoA-I-mediated cholesterol efflux through interaction between cytosolic lipid-protein particles and microtubules in rat astrocytes.
    Kheirollah A; Nagayasu Y; Ueda H; Yokoyama S; Michikawa M; Ito J
    J Neurosci Res; 2014 Apr; 92(4):455-63. PubMed ID: 24446142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.
    Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA
    FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes.
    Azizidoost S; Babaahmadi-Rezaei H; Nazeri Z; Cheraghzadeh M; Kheirollah A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159069. PubMed ID: 34744007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.
    Hirsch-Reinshagen V; Zhou S; Burgess BL; Bernier L; McIsaac SA; Chan JY; Tansley GH; Cohn JS; Hayden MR; Wellington CL
    J Biol Chem; 2004 Sep; 279(39):41197-207. PubMed ID: 15269218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effect of Aβ on protein levels of ABCA1 in astrocytes, microglia, and neurons isolated from C57BL/6 mice: an in vitro and in silico study to elucidate the effect of Aβ on ABCA1 in the brain cells.
    Zarezade V; Nazeri Z; Azizidoost S; Cheraghzadeh M; Babaahmadi-Rezaei H; Kheirollah A
    J Biomol Struct Dyn; 2024; 42(1):274-287. PubMed ID: 37105231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier.
    Akanuma S; Ohtsuki S; Doi Y; Tachikawa M; Ito S; Hori S; Asashima T; Hashimoto T; Yamada K; Ueda K; Iwatsubo T; Terasaki T
    Neurochem Int; 2008 May; 52(6):956-61. PubMed ID: 18201804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation.
    Okuhira K; Fitzgerald ML; Tamehiro N; Ohoka N; Suzuki K; Sawada J; Naito M; Nishimaki-Mogami T
    J Biol Chem; 2010 May; 285(21):16369-77. PubMed ID: 20348106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
    Lorenzi I; von Eckardstein A; Cavelier C; Radosavljevic S; Rohrer L
    J Mol Med (Berl); 2008 Feb; 86(2):171-83. PubMed ID: 17906976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxysterols decrease apical-to-basolateral transport of Aß peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells.
    Saint-Pol J; Candela P; Boucau MC; Fenart L; Gosselet F
    Brain Res; 2013 Jun; 1517():1-15. PubMed ID: 23603412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I.
    Duong PT; Collins HL; Nickel M; Lund-Katz S; Rothblat GH; Phillips MC
    J Lipid Res; 2006 Apr; 47(4):832-43. PubMed ID: 16418537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and amyloid-β: evidence for a cross-talk between astrocytes and neuronal cells.
    Canepa E; Borghi R; Viña J; Traverso N; Gambini J; Domenicotti C; Marinari UM; Poli G; Pronzato MA; Ricciarelli R
    J Alzheimers Dis; 2011; 25(4):645-53. PubMed ID: 21483097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.